Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230803 | SCV000290117 | benign | Brugada syndrome | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705278 | SCV000520236 | likely benign | not provided | 2021-06-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618996 | SCV000737447 | likely benign | Cardiovascular phenotype | 2015-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001801565 | SCV002049521 | likely benign | Brugada syndrome 2 | 2021-02-04 | criteria provided, single submitter | clinical testing |